Holen Sie sich die Stockscreener-App
37.88
4.87%
-1.94
Vorhandelsmarkt:
37.70
-0.18
-0.48%
Schlusskurs vom Vortag:
$39.82
Offen:
$39.65
24-Stunden-Volumen:
16.32M
Relative Volume:
0.62
Marktkapitalisierung:
$8.62B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
54.90
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
+2.19%
1M Leistung:
-7.72%
6M Leistung:
-31.44%
1J Leistung:
+22.71%
1-Tages-Spanne:
$37.61
$39.78
1-Wochen-Bereich:
$37.61
$40.99
52-Wochen-Spanne:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
37.88 | 9.06B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Expands Weight Loss Program to the U.K. - Yahoo Finance
Hims & Hers (HIMS) Expands Weight Loss Program to the UK - GuruFocus
HIMS Expands Weight Loss Program to the UK - GuruFocus
Hims & Hers brings weight loss program to the U.K. (HIMS:NYSE) - Seeking Alpha
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK - PA Media
Hims & Hers launches weight loss program in UK with Hers platform - StreetInsider
Hims and Hers to offer weight-loss treatments in UK - Reuters
Does The Rally In Hims And Hers Health Still Leave Room For Growth In 2025 - Yahoo Finance
(HIMS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
What Analysts Think Is Changing the Hims and Hers Story for Long Term Investors - Yahoo Finance
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? - Finviz
Barclays Initiates Coverage on Hims & Hers Health (HIMS) with Ov - GuruFocus
5 High Short-Interest Stocks to Buy Before Q1 2026 - MarketBeat
XTX Topco Ltd Cuts Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Barclays Initiates Hims & Hers Health With Overweight Rating, $48 Price Target - marketscreener.com
Hims & Hers' YourBio Health Acquisition: How They Are About To Revolutionize Blood Testing! - Smartkarma
Barclays Initiates Coverage of HIMS with Positive Outlook - GuruFocus
Andrew Dudum: 100 Most Influential People in Healthcare 2025 - Modern Healthcare
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Pharma company eyes Canada as patents lapse on weight-loss drugs - Benefits and Pensions Monitor
Truist Securities reiterates Hold rating on Hims and Hers stock amid soft Q4 trends - Investing.com UK
Divisadero Street Capital Management LP Sells 646,934 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Why Hims & Hers Stock Slipped Today - AOL.com
Promising Healthcare Stocks To Add to Your WatchlistDecember 7th - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Q3 Earnings and Telehealth Trends - Quiver Quantitative
Jump Financial LLC Sells 155,479 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: The Market's Panic Is Irrational (NYSE:HIMS) - Seeking Alpha
Arrowstreet Capital Limited Partnership Has $28.36 Million Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Stake Lowered by State Board of Administration of Florida Retirement System - MarketBeat
Clear Street LLC Invests $83.58 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Remin - The National Law Review
HIMS HERS HEALTH INC - Financial Post
Hims and Hers acquires Livewell ahead of generic Ozempic launch in Canada - Financial Post
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves - TradingView
Hims & Hers Continues Major International Expansion With Officia - GuruFocus
Leerink Partnrs Upgrades Hims & Hers Health (NYSE:HIMS) to Strong-Buy - MarketBeat
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm - Finviz
Norges Bank Makes New $78.46 Million Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity (NYSE:HIMS) - Seeking Alpha
American Century Companies Inc. Buys 42,510 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Stock Gains on Move Into Canada - The Wall Street Journal
Notable Thursday Option Activity: HIMS, GAP, BE - Nasdaq
Hims & Hers Health, Inc. acquired Livewell. - marketscreener.com
Hims & Hers Snaps Up YourBio To Bring Pain-Free Blood Tests Home - Sahm
Hims & Hers propose désormais ses services aux clients du Canada - Hastings Tribune
Hims & Hers expands into diagnostics, moves into Canada as it evolves DTC telehealth platform - Fierce Healthcare
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency - Yahoo Finance
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):